Catalog Advanced Search
205 Results
-
Includes a Live Web Event on 01/20/2027 at 11:00 AM (PST)
Content provided by Siemens Healthineers (No CE credits offered)
Webinar Description:
Join this sponsored webinar to learn how point-of-care lactate testing can accelerate decision-making, improve compliance, and support faster, more coordinated sepsis care.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Siemens Healthineers for this sponsored webinar.
Patti DeJuilio, MS, RRT-ACCS, RRT-NPS, FAARC
Director (Ret.) of Respiratory Care and Diagnostic Service
Northwestern Medicine Central DuPage Hospital
Patti DeJuilio, MS, RRT-ACCS, RRT-NPS, FAARC, is the recently retired Director of Respiratory Care and Diagnostic Services at Northwestern Medicine, Central DuPage Hospital in Winfield, IL. She has more than 40 years of experience in respiratory care, with extensive clinical and leadership experience. Patti received a Master of Science degree in Respiratory Care from Rush University and is a Fellow of the American Association of Respiratory Care. She has published and presented her work on many topics, including hospital-acquired pneumonia reduction, early mobility, use of an open-design oxygen mask, and improvements resulting from implementing point-of-care blood gas testing.
-
Includes a Live Web Event on 12/11/2026 at 7:00 AM (PST)
Free virtual conference covering a variety of topics in HAI and AMR
Description:
Healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) are increasingly interconnected threats that jeopardize patient safety, elevate healthcare costs, and raise the risk of infections progressing to sepsis. To address these challenges, the 2026 Sepsis Alliance HAI and AMR Conferencewill bring together experts from across the healthcare spectrum for a virtual event. Attendees will explore the latest evidence, technologies, and strategies in infection prevention, antimicrobial stewardship, and sepsis mitigation. Through expert-led presentations and practical insights, participants will gain a deeper understanding of both clinical and system-level approaches that drive safer, more equitable care.
Topics covered will include:
- Innovations in HAI prevention and surveillance
- Equity considerations in AMR and HAI outcomes
- The link between sepsis, HAIs, and antimicrobial resistance
- Antibiotic stewardship and leadership engagement
- Applications of technology and artificial intelligence in HAI and AMR management
The event will be offered as a free live virtual event with CME for physicians and contact hours for nurses awarded.
Learning Objectives:
At the end of this event, the learner should be able to:
- Describe the relationship between HAIs, AMR, and sepsis, and their combined impact on patient outcomes.
- Apply evidence-based infection prevention and control (IPC) strategies within diverse healthcare settings.
- Identify tools, resources, and stewardship practices that support responsible antimicrobial prescribing.
- Recognize emerging technologies and innovative approaches that strengthen HAI surveillance and AMR mitigation.
- Evaluate system-level opportunities, particularly for leadership and quality teams, to drive meaningful improvement in infection control and antimicrobial stewardship efforts.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Agenda
December 11, 2026
Time (ET) Session Title Presenter 10:00-10:25 Opening Remarks and Patient Story Cindy Hou, DO, MA, MBA, CIC, CPHQ, FACOI, FACP, FIDSA, FAPIC
Infection Control Officer and Medical Director of Research
Jefferson Health - New Jersey
Christina Cole
Sepsis Survivor and Advocate; Founder
Phoenix Health Compass and Phoenix Navigator10:25-10:55 Keynote: The First Line of Defense Is What We Say: Transforming How We Talk About Infection Prevention and AMR Elisabeth Marnik, PhD
Executive Director; Chief Scientific Officer
The Evidence Collective; Those Nerdy Girls11:00-11:30 What's new in the world of urinary tract infections? Payal Patel, MD, MPH, FIDSA
Associate Professor of Infectious Disease; Medical Director of Antimicrobial Stewardship
Intermountain Health11:35-12:05 From Reactive to Proactive: Virtual Surveillance for HAIs and Sepsis Prevention Fiona A. Winterbottom, DNP, MSN, APRN, ACNS-BC, CCRN, FCCM
Manager, Virtual Critical Care
Ochsner Health, New Orleans, Louisiana12:10-12:25 Healthcare–Associated Infections in U.S. Hospitals, 2023 versus 2015 Nora Chea, MD, MSc
Medical Epidemiologist
Centers for Disease Control and Prevention (CDC)12:25-12:40 Break 12:40-1:10 Danaher Sponsored Session: Diagnostic Excellence in Sepsis: Connecting HAI Risk Recognition, Rapid Diagnostics, and Antimicrobial Stewardship Lucas Schulz, PharmD
Medical Science Liasion
Cepheid1:15-1:30 CorMedix Sponsored Session: Decoding CRE: How Carbapenemase Testing Guides Optimal Care Erin McCreary, PharmD, BCPS, BCIDP
Clinical Assistant Professor of Medicine
University of Pittsburgh School of Medicine1:30-1:45 Break 1:45-2:15 Patient Story 2:20-2:50 Antivirals as Infrastructure: The Missing Pillar for Prevention of HAI and Sepsis Amesh Adalja, MD, FIDSA
Adjunct Assistant Professor
John Hopkins Bloomberg School of Public Health2:55-3:25 Impact of Oral Care in Non-Ventilated ICU Patients on Hospital-Onset Bacteremia Secondary to Pneumonia Elysse Gutierrez, MSN, RN, CIC
Infection Preventionist
Ascension Seton Williamson3:30-4:00 Candida auris Update: Tracking the Shift from Colonization to Infection Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA
Field Medical Officer
Division of Healthcare Quality Promotion, Centers for Disease Control c/o New York State Department of Health
Meghan Lyman, MD
Acting Deputy Branch Chief
Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention4:05-4:35 Advancing Hospital Antimicrobial Stewardship to Combat Emerging Resistance Mechanisms and Optimize Therapy Thomas Lavoie, PharmD
Senior Program Manager, AHA Funded Partnerships
American Hospital Association5:10-5:15 Closing Remarks -
Includes a Live Web Event on 12/03/2026 at 11:00 AM (PST)
Content provided by MeMed(No CE credits offered)
Webinar Description:
Sepsis alerts in the emergency department drive urgent decisions about antibiotics and admission, often before the cause of infection is clear. This sponsored webinar will feature Brian K. DuChateau, PhD, D(ABMLI), U.S. Head of Medical Affairs at MeMed and a board-certified clinical laboratory immunologist with more than 20 years of experience as a clinical laboratory director. Dr. DuChateau will introduce MeMed BV®, an innovative host-response test that helps differentiate bacterial and viral infections. He will then introduce Jason Wilson, MD, PhD, CPE, FACEP, Chief of Emergency Medicine at Tampa General Hospital, who will dive deep into his real-world experience integrating MeMed BV into ED sepsis workflows. Dr. Wilson will cover how MeMed BV can inform admission and antibiotic decisions, support clinicians in categorizing patients as possible or unlikely bacterial sepsis, and help reduce unnecessary costs, drawing on real-world data from Tampa General Hospital.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by MeMed for this sponsored webinar.
Brian K. DuChateau, PhD, D(ABMLI)
US Head of Medical Affairs
MeMed
Brian K. DuChateau, Ph.D., D(ABMLI), is a board-certified clinical laboratory immunologist. He received his Ph.D. in immunology and medical microbiology from the University of Wisconsin-Madison and completed a postdoctoral residency in clinical immunology at the Chicago Medical School. Dr. DuChateau has over 20 years of experience as a clinical laboratory director and 12 years of in vitro diagnostics (IVD) experience. He has served as a Clinical Laboratory Director at various clinical diagnostic reference laboratories and has held senior leadership positions at several IVD companies. He has been with MeMed since 2023 and currently serves as the U.S. Head of Clinical Affairs.
Jason Wilson, MD, PhD, CPE, FACEP
Chief of Emergency Medicine
Tampa General Hospital
Jason W. Wilson, MD, PhD, CPE, FACEP, is Professor and Founding Chair of the Department of Emergency Medicine at the University of South Florida Morsani College of Medicine.
At Tampa General Hospital (TGH), he is Chief of Emergency Medicine and Vice President and Academic Co-Chief of the Emergency Services Institute. His leadership work spans emergency care delivery and coordination across the TGH academic health system. Dr. Wilson is board-certified in Emergency Medicine by the American Board of Emergency Medicine and in Addiction Medicine by the American Board of Preventive Medicine.
He earned his PhD in Anthropology at USF in December 2023 and holds an affiliate faculty appointment in the USF Department of Anthropology. His research applies anthropological theory and methods to the development of patient care pathways, including work in substance use disorders, HIV and hepatitis C, sepsis, traumatic brain injury, and anticoagulation and bleeding management.
-
Includes a Live Web Event on 11/12/2026 at 11:00 AM (PST)
Content provided by Kurin, Inc. (No CE credits offered)
Webinar Description:
Reducing blood culture contamination isn’t the responsibility of a single department; it takes collaboration across the organization. In this sponsored panel discussion, leaders from emergency nursing education, sepsis program management and quality, and infection prevention will share their real-world experiences working together to improve blood culture quality and drive sustainable change. Panelists will discuss their approaches to reducing blood culture contamination, the role of cross-functional leadership and accountability, and how their partnership with Kurin has supported sustained improvements and financial savings. Attendees will leave with practical strategies they can apply within their own organizations as they work toward blood culture contamination rates below 1%.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Kurin, Inc. for this sponsored webinar.
Heidi Gilbert, MSN, RN, CEN, TCRN, SANE-A
Emergency Department Clinical Educator and SANE Program Coordinator
Stillwater Medical Center
Heidi Gilbert, MSN, RN, CEN, TCRN, SANE-A, is an emergency nursing leader with more than 25 years of clinical experience spanning emergency care, trauma, forensic nursing, and nursing education. She currently serves as Emergency Department Clinical Educator and SANE Program Coordinator at Stillwater Medical Center and is in her third year on the Emergency Nurses Association Board of Directors. A certified Sexual Assault Nurse Examiner, Heidi is passionate about advancing emergency nursing, rural healthcare, and trauma-informed care through education, advocacy, and clinical leadership.
Robbie Mae Lopez, RN, BSN, CIC, CPHQ
Infection Prevention Manager
Sutter Health
Robbie Mae Lopez, RN, BSN, CIC, CPHQ, is a healthcare quality and infection prevention leader with more than 20 years of experience in acute care, patient safety, regulatory compliance, and healthcare epidemiology. Board-certified in Infection Prevention and Control and Healthcare Quality, she specializes in healthcare-associated infection reduction, outbreak response, accreditation readiness, and performance improvement. Robbie has successfully partnered with multidisciplinary healthcare teams to implement evidence-based solutions that improve patient outcomes, strengthen regulatory compliance, and advance cultures of safety.
Gigi Guan, MSN, RN, PHN, CEN, TCRN, CPEN
Clinical Effectiveness Consultant III
Sutter Health
Gigi Guan, MSN, RN, PHN, CEN, TCRN, CPEN, is a quality improvement leader with 13+ years of nursing and healthcare leadership experience driving multidisciplinary performance improvement initiatives across acute care. Her expertise includes patient safety, clinical quality, evidence-based practice implementation, workflow redesign, performance measurement, and change leadership. She has proven success partnering with physicians, nursing leaders, multidisciplinary teams, and executive leadership to improve patient outcomes, CMS core measures, organizational quality metrics, and operational performance through data-driven decision-making and collaboration.
Abby Norfleet (Moderator)
Executive VP of Sales
Kurin, Inc.
Abby Norfleet is an accomplished healthcare executive with nearly two decades of experience spanning critical care nursing, clinical education, consulting, and strategic leadership. Her career combines frontline clinical expertise with executive sales leadership focused on improving patient outcomes and strategic growth across health systems. Abby began her career as a critical care nurse in a nationally recognized Level I trauma center, an experience that continues to inform her outcomes-driven leadership approach. Prior to joining Kurin, Abby served in leadership roles at 3M Corporation following its acquisition of Ivera Medical Corporation, where she was instrumental in driving clinical integration initiatives and sustaining customer outcomes nationally. She later led the 3M Clinical Outcomes Team before advancing to Strategic Solutions Director, leading partnerships with large integrated delivery networks (IDNs) to develop enterprise-level clinical and operational solutions. As EVP of Sales at Kurin, Abby leads commercial growth initiatives while partnering with health systems to improve patient safety, clinical outcomes, and economic performance.
-
Content provided by Roche (No CE credits offered)
Webinar Description:
Neonatal and pediatric sepsis present unique clinical challenges, ranging from non-specific symptoms to the limitations of traditional blood cultures in tiny patients. This sponsored webinar explores how diagnostic strategies and biomarkers, including Procalcitonin (PCT) and Interleukin-6 (IL-6) can help cut through the clinical noise. Join us to learn about early detection, enable targeted therapies, and safely reduce empiric antibiotic use in our most vulnerable patients.
This course was originally recorded on October 22, 2026.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Roche for this sponsored webinar.
Emin Maltepe, MD, PhD
Professor of Pediatrics
University of California San Francisco
Emin Maltepe, MD, PhD, is a Professor of Pediatrics at UCSF. His research laboratory studies mechanisms whereby hypoxia signaling pathways regulate normal development, contribute to the origins of pregnancy complications, and drive disease processes such as pulmonary hypertension and retinopathy of prematurity in newborn infants. Additionally, he is a co-founder of the Initiative for Pediatric Drug and Device Development (www.ipd3.org), a multi-institutional collaborative comprised of leaders in pediatrics and pharmaceutical sciences that functions as a ”one-stop-shop” to advance drug and device development for pediatric indications. In this capacity, the collaborative has been working with non-profit and industry sponsors on multiple fronts, including neurotherapeutics for birth asphyxia, novel oxygen delivery biotherapeutics for treatment of hemorrhagic shock, as well as cardioprotective agents for infants undergoing repair of congenital heart defects. He is additionally helping advise the development of novel diagnostic modalities specifically targeting sepsis as well as brain injury in newborn infants.
-
This webinar describes updates to pediatric sepsis guidelines.
Description:
The 2026 Surviving Sepsis Campaign Guidelines for Children introduce updated recommendations for the recognition and management of pediatric sepsis and septic shock. This webinar will examine how new evidence may influence clinical decision-making across the continuum of care, from initial evaluation through treatment and ongoing management. Through case-based examples, attendees will consider practical approaches for incorporating the recommendations into clinical workflows, institutional pathways, and quality improvement efforts. Ample time will be reserved for audience questions and clarification about applying the guidelines in diverse pediatric care settings.
This course was originally recorded on October 13, 2026.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Restate key changes in the 2026 Pediatric Surviving Sepsis Guidelines and identify the supporting evidence;
- Apply the updated recommendations to the evaluation and management of children with suspected sepsis and septic shock using case-based clinical scenarios;
- Develop strategies to implement the 2026 guideline recommendations within local clinical pathways and quality improvement initiatives to promote timely, evidence-based pediatric sepsis care.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Scott L. Weiss, MD, MSCE, FCCM
Division Chief, Critical Care Medicine, Vice Chair for Research, Department of Pediatrics
Sidney Kimmel Medical Center at Thomas Jefferson University, Nemours Children's Hospital, Delaware
Scott L. Weiss, MD, MSCE, FCCM is Division Chief of Critical Care and Vice-Chair for Research in the Department of Pediatrics at Nemours Children’s Hospital (DuPont)-Delaware and Professor of Pediatrics & Pathology and Genomic Medicine at the Sidney Kimmel Medical College of Thomas Jefferson University. He has served as the co-Vice Chair for the Pediatric Surviving Sepsis Campaign for the 2020 and 2026 iterations, and has published widely on pediatric sepsis recognition, management, and pathology. Dr. Weiss’ research focuses on epidemiology and mitochondrial dysfunction in pediatric sepsis, including risk factors, biomarkers, and mechanisms of sepsis-induced immune dysregulation and organ dysfunction. He is also the co-PI of the multinational Pragmatic Pediatric Trial of Balanced versus Normal Saline fluid in Sepsis (PRoMPT BOLUS).
Lauren Sorce, PhD, RN, CPNP-AC/PC, CCRN, FCCM, FAAN
Senior Director Nursing Research and Operations; Assistant Professor of Pediatrics (Critical Care); Pediatric Critical Care APRN
Posy and Fred Love Chair in Nursing Research, Ann & Robert H. Lurie Children’s Hospital of Chicago and Stanley Manne Children’s Research Institute; Northwestern University Feinberg School of Medicine; Ann & Robert H. Lurie Children’s Hospital of Chicago
Lauren R. Sorce, PhD, RN, CPNP-AC/PC, FCCM, FAAN is the Senior Director Nursing Research and Operations at Ann & Robert H. Lurie Children’s Hospital of Chicago and Stanley Manne Children’s Research Institute where she also holds the Posy and Fred Love Chair in Nursing Research. She is the Senior Scientist in the Division of Pediatric Critical Care Medicine at Ann & Robert H. Lurie Children’s Hospital of Chicago where she has practiced as a Pediatric Critical Care Nurse Practitioner for 28 years. She is an Assistant Research Professor at Northwestern University, Feinberg School of Medicine. She received both her Bachelor’s and Master’s of Science in Nursing from Loyola University, followed by her post-Masters Pediatric Nurse Practitioner certificate and her PhD from Rush University.
Dr. Sorce is Past President of the Society of Critical Care Medicine, the first pediatric nurse serving as President of the multiprofessional Critical Care Society since its inception in 1971. Dr. Sorce had a research interest for years bringing many multicentered trials to the PICU. She has also been funded to study corneal abrasions and worked on numerous research teams to study post-intensive care syndrome, stress hydrocortisone in pediatric septic shock, positioning in PARDS, and criteria for convening family conferences in the ICU. She has reset the clinical research strategy in the PICU over the past several years where she has led monthly research operations meetings and a monthly Think Tank.
Her current work is investigating severity of illnesses associated with the nasopharyngeal microbiome. Dr. Sorce was co-vice chair of the SCCM Taskforce for the development of the PHOENIX pediatric Sepsis score and participated in the development of the Surviving Sepsis Campaign Pediatric Guidelines. She has served in leadership roles on numerous local and international committees as well as participating on editorial boards.
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.
Financial Relationship Disclosure for All Individuals in Control of Content
All individuals in control of content disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Content provided by Abbott (No CE credits offered)
Webinar Description:
When sepsis patients move between care settings, every handoff matters. In this sponsored webinar, discover why care transitions break down, how lactate monitoring can reveal early signs of deterioration, and how data-driven communication empowers care teams. Explore proven strategies, smarter handoffs, and innovative technologies that help reduce readmissions and deliver safer, more connected recovery.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Abbott for this sponsored webinar.
Other Abbott Webinars:
Register for Beyond the ICU: The Role of Lactate in Sepsis, Recovery, and Readmission Risk
Laurence Busse, MD, MBA, FCCM
Associate Professor of Medicine, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine
Emory University
Laurence Busse, M.D., MBA, FCCM, is a Distinguished Physician and an Associate Professor of Medicine within the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine at Emory University. He is boarded in Internal Medicine and Critical Care Medicine. Dr. Busse served as the Medical Director of Critical Care at Emory Johns Creek Hospital and the Site Director of the Emory Critical Care Center (ECCC) for Johns Creek, until turning his attention to medical education and increasing access to clinical trials for patients in underserved areas. To this end, Dr. Busse founded and now leads the Satellite Trials Group of Emory (STaGE), a multi-site distributed clinical trials platform that brings together investigators from multiple Emory locations in the execution of translational research outside of traditional academic settings. Dr. Busse’s research focuses on sepsis and septic shock, and the role that novel therapeutics and theragnostics play in disease management. Dr. Busse is a recipient of the Emory Critical Care Center’s Timothy G. Buchman Award in Transformational Leadership. He is a Fellow of the American College of Critical Care Medicine.
-
Annual, virtual conference covering sepsis-related topics and offering CME Credits and RN CE Contact Hours
Description:
This year’s program features forward‑looking presentations from clinicians, researchers, innovators, patient advocates, and national leaders who are shaping the future of sepsis care.
Healthcare professionals can earn free AMA PRA Category 1 Credit(s)™ or RN CE credits through engaging, practice-focused sessions that explore the latest science, technologies, and system‑level strategies driving improvement in sepsis outcomes.
Learning Objectives:
At the end of this event, the learner should be able to:
- Differentiate current sepsis definitions, diagnostic tools, and clinical criteria across diverse populations, including pediatric and hospital-acquired cases;
- Describe evidence-based strategies that strengthen early recognition, timely intervention, antimicrobial stewardship, and post-discharge monitoring to improve outcomes;
- List system-level drivers of quality improvement, such as SEP-1, CDI, HVBP, certification pathways, and collaborative models which can be developed into sustainable sepsis care programs;
- Evaluate innovative tools, including artificial intelligence, advanced diagnostics, and media-based education, to enhance personalized sepsis management;
- Apply trauma-informed approaches that address the experiences of co-survivors and foster healthcare environments that support patients, families, and providers.
Accreditation Statements
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 9.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 7.25 contact hours.
Financial Relationship Disclosures:
All individuals in control of content disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Part of Sepsis Alliance Summit 2026
Description:
This session was part of Sepsis Alliance Summit 2026
This keynote, Lessons from Sepsis History, will trace the evolution of sepsis from antiquity to modern medicine, exploring how historical concepts have shaped current understanding and care. Participants will examine sepsis as a complex syndrome influenced by uncertainty, quality improvement movements, and modern approaches to recognition and treatment. The session will also highlight key drivers of today’s sepsis burden, including antimicrobial resistance, health inequities, and healthcare system challenges.
Lesson Objectives:
At the end of this session, the learner should be able to:
- Appreciate how the early historical framing of sepsis as “blood poisoning,” and subsequent definitional paradigms, have shaped, and at times constrained, our current understanding of the syndrome;
- Recognize sepsis as a problem of complexity and identify key drivers of sepsis incidence and mortality, such as antimicrobial resistance, systemic faultlines within healthcare, and social determinants of health;
- Connect current paradigms of prevention, early recognition, and structured care with the broader quality improvement efforts of the twenty-first century.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Parsa Shahinpoor, MD
Hospitalist and Quality Improvement Leader
Northwest Permanente PC
Parsa Shahinpoor, MD, is a frontline hospitalist, teaching physician, and quality improvement leader at Kaiser Permanente Northwest, where he has spent nearly two decades advancing sepsis care–, a role that has connected him with experts around the world. He completed his medical training at the University of New Mexico Health Sciences Center, where he served as an assistant professor of medicine and directed the internal medicine medical student clerkship. He is the author of Blood Poison: The Untold Story of Sepsis (Amplify Publishing, July 2026), available at BloodPoison.com. Blending science, history, and narrative, he writes to make one of medicine's most urgent challenges vivid and accessible, bringing to life the patients and families whose stories illuminate the human cost of sepsis. Outside of medicine, Dr. Shahinpoor is passionate about playing and composing classical and modern piano. He also enjoys mountaineering, windsurfing, and stand-up paddleboarding in the Pacific Northwest.
-
Live webinar describing updates to pediatric sepsis guidelines
Description:
Date: Tuesday, October 13, 2026
Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT
The 2026 Surviving Sepsis Campaign Guidelines for Children introduce updated recommendations for the recognition and management of pediatric sepsis and septic shock. This webinar will examine how new evidence may influence clinical decision-making across the continuum of care, from initial evaluation through treatment and ongoing management. Through case-based examples, attendees will consider practical approaches for incorporating the recommendations into clinical workflows, institutional pathways, and quality improvement efforts. Ample time will be reserved for audience questions and clarification about applying the guidelines in diverse pediatric care settings.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Restate key changes in the 2026 Pediatric Surviving Sepsis Guidelines and identify the supporting evidence;
- Apply the updated recommendations to the evaluation and management of children with suspected sepsis and septic shock using case-based clinical scenarios;
- Develop strategies to implement the 2026 guideline recommendations within local clinical pathways and quality improvement initiatives to promote timely, evidence-based pediatric sepsis care.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Scott L. Weiss, MD, MSCE, FCCM
Division Chief, Critical Care Medicine, Vice Chair for Research, Department of Pediatrics
Sidney Kimmel Medical Center at Thomas Jefferson University, Nemours Children's Hospital, Delaware
Scott L. Weiss, MD, MSCE, FCCM is Division Chief of Critical Care and Vice-Chair for Research in the Department of Pediatrics at Nemours Children’s Hospital (DuPont)-Delaware and Professor of Pediatrics & Pathology and Genomic Medicine at the Sidney Kimmel Medical College of Thomas Jefferson University. He has served as the co-Vice Chair for the Pediatric Surviving Sepsis Campaign for the 2020 and 2026 iterations, and has published widely on pediatric sepsis recognition, management, and pathology. Dr. Weiss’ research focuses on epidemiology and mitochondrial dysfunction in pediatric sepsis, including risk factors, biomarkers, and mechanisms of sepsis-induced immune dysregulation and organ dysfunction. He is also the co-PI of the multinational Pragmatic Pediatric Trial of Balanced versus Normal Saline fluid in Sepsis (PRoMPT BOLUS).
Lauren Sorce, PhD, RN, CPNP-AC/PC, CCRN, FCCM, FAAN
Senior Director Nursing Research and Operations; Assistant Professor of Pediatrics (Critical Care); Pediatric Critical Care APRN
Posy and Fred Love Chair in Nursing Research, Ann & Robert H. Lurie Children’s Hospital of Chicago and Stanley Manne Children’s Research Institute; Northwestern University Feinberg School of Medicine; Ann & Robert H. Lurie Children’s Hospital of Chicago
Lauren R. Sorce, PhD, RN, CPNP-AC/PC, FCCM, FAAN is the Senior Director Nursing Research and Operations at Ann & Robert H. Lurie Children’s Hospital of Chicago and Stanley Manne Children’s Research Institute where she also holds the Posy and Fred Love Chair in Nursing Research. She is the Senior Scientist in the Division of Pediatric Critical Care Medicine at Ann & Robert H. Lurie Children’s Hospital of Chicago where she has practiced as a Pediatric Critical Care Nurse Practitioner for 28 years. She is an Assistant Research Professor at Northwestern University, Feinberg School of Medicine. She received both her Bachelor’s and Master’s of Science in Nursing from Loyola University, followed by her post-Masters Pediatric Nurse Practitioner certificate and her PhD from Rush University.
Dr. Sorce is Past President of the Society of Critical Care Medicine, the first pediatric nurse serving as President of the multiprofessional Critical Care Society since its inception in 1971. Dr. Sorce had a research interest for years bringing many multicentered trials to the PICU. She has also been funded to study corneal abrasions and worked on numerous research teams to study post-intensive care syndrome, stress hydrocortisone in pediatric septic shock, positioning in PARDS, and criteria for convening family conferences in the ICU. She has reset the clinical research strategy in the PICU over the past several years where she has led monthly research operations meetings and a monthly Think Tank.
Her current work is investigating severity of illnesses associated with the nasopharyngeal microbiome. Dr. Sorce was co-vice chair of the SCCM Taskforce for the development of the PHOENIX pediatric Sepsis score and participated in the development of the Surviving Sepsis Campaign Pediatric Guidelines. She has served in leadership roles on numerous local and international committees as well as participating on editorial boards.
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.
Financial Relationship Disclosure for All Individuals in Control of Content
All individuals in control of content disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.